Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Ziprasidone, sold under the brand name Geodon among others, is an atypical antipsychotic used to treat schizophrenia and bipolar disorder. It may be used by mouth and by injection into a muscle (IM). The intramuscular form may be used for acute agitation in people with schizophrenia.
History, Community, Culture & Applications
Explore the main themes, entities and connections around Ziprasidone. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
antipsychotics schizophrenia may also effects atypical symptoms intramuscular serotonin dopamine include used geodon antipsychotic side weight approved drugs drug less
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Ziprasidone | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Ziprasidone | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Ziprasidone | ATC code | N05AE04 (WHO) | 1.00 | infobox |
| Ziprasidone | Bioavailability | Oral: 60% IMTooltip Intramuscular injection: 100% | 1.00 | infobox |
| Ziprasidone | CAS Number | 146939-27-7 Y | 1.00 | infobox |
| Ziprasidone | ChEBI | CHEBI:10119 Y | 1.00 | infobox |
| Ziprasidone | ChEMBL | ChEMBL708 Y | 1.00 | infobox |
| Ziprasidone | ChemSpider | 54841 Y | 1.00 | infobox |
| Ziprasidone | CompTox Dashboard (EPA) | DTXSID4023753 | 1.00 | infobox |
| Ziprasidone | Drug class | Atypical antipsychotic | 1.00 | infobox |
| Ziprasidone | DrugBank | DB00246 Y | 1.00 | infobox |
| Ziprasidone | ECHA InfoCard | 100.106.954 | 1.00 | infobox |
| Ziprasidone | Elimination half-life | 7–10 hours | 1.00 | infobox |
| Ziprasidone | Excretion | Urine and feces | 1.00 | infobox |
| Ziprasidone | Formula | C21H21ClN4OS | 1.00 | infobox |
| Ziprasidone | IUPHAR/BPS | 59 | 1.00 | infobox |
| Ziprasidone | KEGG | D08687 Y | 1.00 | infobox |
| Ziprasidone | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Ziprasidone | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Ziprasidone | Legal status | US: ℞-only | 1.00 | infobox |
| Ziprasidone | License data | US DailyMed: Ziprasidone | 1.00 | infobox |
| Ziprasidone | MedlinePlus | a699062 | 1.00 | infobox |
| Ziprasidone | Metabolism | Liver (aldehyde reductase) | 1.00 | infobox |
| Ziprasidone | Molar mass | 412.94 g·mol−1 | 1.00 | infobox |
| Ziprasidone | Pregnancy category | AU: C | 1.00 | infobox |
| Ziprasidone | PubChem CID | 60854 | 1.00 | infobox |
| Ziprasidone | Routes of administration | Oral, intramuscular | 1.00 | infobox |
| Ziprasidone | Trade names | Geodon, others | 1.00 | infobox |
| Ziprasidone | UNII | 6UKA5VEJ6X | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.